Roth Positive on BioLineRx (BLRX) Amid Latest BL-8040 Phase 2a Data in r/r AML

Go back to Roth Positive on BioLineRx (BLRX) Amid Latest BL-8040 Phase 2a Data in r/r AML
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.71 -0.05 (1.81%)
Previous Close $2.76    52 Week High $1.63 
Open $2.76    52 Week Low $0.71 
Day High $2.86    P/E N/A 
Day Low $2.71    EPS $0.00 
Volume 6,350